Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors (Q2684584)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors |
scientific article; zbMATH DE number 7654611
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors |
scientific article; zbMATH DE number 7654611 |
Statements
Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors (English)
0 references
16 February 2023
0 references
SARS-CoV-2
0 references
COVID-19
0 references
virus dynamics
0 references
clinical trial
0 references
0.6678915023803711
0 references
0.6658905148506165
0 references
0.658807635307312
0 references
0.644520103931427
0 references
0.6399579644203186
0 references
